Literature DB >> 21505351

Comparison of central pressure estimates obtained from SphygmoCor, Omron HEM-9000AI and carotid applanation tonometry.

Jan G Kips1, Aletta E Schutte, Sebastian J Vermeersch, Hugo W Huisman, Johannes M Van Rooyen, Matthew C Glyn, Catharina M Fourie, Leone Malan, Rudolph Schutte, Luc M Van Bortel, Patrick Segers.   

Abstract

BACKGROUND: The Omron HEM-9000AI is the first automated tonometer to provide an estimate of central SBP (cSBP), which is considered to be more predictive of cardiovascular events than brachial pressure. However, considerable differences between the cSBP estimate of Omron and that of SphygmoCor have been reported, but not explained. This study assesses the sources of differences between both cSBP estimates and provides a handle on which estimate is closest to reality.
METHOD: For this purpose, aortic cSBP derived from calibrated carotid SBP was used as device- and algorithm-independent reference. Radial, brachial and carotid applanation tonometry were performed in 143 black South Africans, aged 39-91 years. Each individual was measured with an Omron HEM-9000AI and a SphygmoCor.
RESULTS: When using both devices as advocated by their manufacturers, the corresponding cSBP estimates correlated strongly (r = 0.99, P < 0.001), but the Omron estimate was 18.8 (4.3) mmHg higher than the SphygmoCor estimate. Aortic SBP was in between both estimates: 11.7 (5.5) mmHg lower than cSBP-Omron and 7.1 (5.0) mmHg higher than cSBP-SphygmoCor. Alternative calibration of the radial SphygmoCor-curves with radial instead of brachial pressures yielded a cSBP that was 3.0 (4.2) mmHg lower than aortic SBP. The shape of the recorded pressure waves was similar in both devices: less than 5% of the observed cSBP difference was caused by differences in wave shape.
CONCLUSION: The results from this study demonstrate that the considerable difference between the central pressure estimates of Omron HEM-9000AI and SphygmoCor is due to algorithm differences, and suggest that the overestimation by Omron HEM-9000AI is larger than the underestimation by SphygmoCor.

Entities:  

Mesh:

Year:  2011        PMID: 21505351     DOI: 10.1097/HJH.0b013e328346a3bc

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  15 in total

Review 1.  Noninvasive studies of central aortic pressure.

Authors:  Michael F O'Rourke; Audrey Adji
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

2.  Older age is associated with greater central aortic blood pressure following the exercise stress test in subjects with similar brachial systolic blood pressure.

Authors:  Masatake Kobayashi; Kazutaka Oshima; Yoichi Iwasaki; Yuto Kumai; Alberto Avolio; Akira Yamashina; Kenji Takazawa
Journal:  Heart Vessels       Date:  2015-08-21       Impact factor: 2.037

Review 3.  Does Measurement of Central Blood Pressure have Treatment Consequences in the Clinical Praxis?

Authors:  Gary F Mitchell
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

4.  Measurement of central augmentation index by three different methods and techniques: Agreement among Arteriograph, Complior, and Mobil-O-Graph devices.

Authors:  Theodore G Papaioannou; John Thymis; Dimitrios Benas; Helen Triantafyllidi; Gavriela Kostelli; George Pavlidis; Fotini Kousathana; Kostantinos Katogiannis; Dimitrios Vlastos; Vaia Lambadiari; Evangelia Papadavid; John Parissis; Dimitrios Tousoulis; Ignatios Ikonomidis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-08-29       Impact factor: 3.738

Review 5.  Central blood pressure: current evidence and clinical importance.

Authors:  Carmel M McEniery; John R Cockcroft; Mary J Roman; Stanley S Franklin; Ian B Wilkinson
Journal:  Eur Heart J       Date:  2014-01-23       Impact factor: 29.983

Review 6.  Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension.

Authors:  Paolo Palatini; Edoardo Casiglia; Jerzy Gąsowski; Jerzy Głuszek; Piotr Jankowski; Krzysztof Narkiewicz; Francesca Saladini; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Luc Van Bortel; Wiktoria Wojciechowska; Kalina Kawecka-Jaszcz
Journal:  Vasc Health Risk Manag       Date:  2011-12-07

7.  Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients.

Authors:  Tomohiko Kanaoka; Kouichi Tamura; Masato Ohsawa; Hiromichi Wakui; Akinobu Maeda; Toru Dejima; Kengo Azushima; Sona Haku; Hiroshi Mitsuhashi; Mai Yanagi; Jin Oshikawa; Kazushi Uneda; Kazutaka Aoki; Tetsuya Fujikawa; Yoshiyuki Toya; Kazuaki Uchino; Satoshi Umemura
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-03       Impact factor: 3.738

8.  Effects of single pill-based combination therapy of amlodipine and atorvastatin on within-visit blood pressure variability and parameters of renal and vascular function in hypertensive patients with chronic kidney disease.

Authors:  Kengo Azushima; Kazushi Uneda; Kouichi Tamura; Hiromichi Wakui; Masato Ohsawa; Ryu Kobayashi; Toru Dejima; Tomohiko Kanaoka; Akinobu Maeda; Yoshiyuki Toya; Satoshi Umemura
Journal:  Biomed Res Int       Date:  2014-04-08       Impact factor: 3.411

9.  Differential response of central blood pressure to isometric and isotonic exercises.

Authors:  Satoru Tanaka; Tomonori Sugiura; Sumiyo Yamashita; Yasuaki Dohi; Genjiro Kimura; Nobuyuki Ohte
Journal:  Sci Rep       Date:  2014-06-25       Impact factor: 4.379

10.  Associations between remnant lipoprotein cholesterol and central systolic blood pressure in a Chinese community-based population: a cross-sectional study.

Authors:  Jing Zhou; Yan Zhang; Kaiyin Li; Fangfang Fan; Bo Zheng; Jia Jia; Bo Liu; Jiahui Liu; Chuyun Chen; Yong Huo
Journal:  Lipids Health Dis       Date:  2021-06-26       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.